Skip to main content
Erschienen in: European Journal of Epidemiology 12/2008

01.12.2008 | Cardiovascular Disease

Diabetes and modifiable risk factors for cardiovascular disease: the prospective Million Women Study

verfasst von: Elizabeth A. Spencer, Kirstin L. Pirie, Richard J. Stevens, Valerie Beral, Anna Brown, Bette Liu, Jane Green, Gillian K. Reeves, Million Women Study Collaborators

Erschienen in: European Journal of Epidemiology | Ausgabe 12/2008

Einloggen, um Zugang zu erhalten

Abstract

To compare the effect of potentially modifiable lifestyle factors on the incidence of vascular disease in women with and without diabetes. In 1996–2001 over one million middle-aged women in the UK joined a prospective study, providing medical history, lifestyle and socio-demographic information. All participants were followed for hospital admissions and deaths using electronic record-linkage. Adjusted relative risks (RRs) and incidence rates were calculated to compare the incidence of coronary heart disease and stroke in women with and without diabetes and by lifestyle factors. At recruitment 25,915 women (2.1% of 1,242,338) reported current treatment for diabetes. During a mean follow-up of 6.1 years per woman, 21,928 had a first hospital admission or death from coronary heart disease (RR for women with versus without diabetes = 3.30, 95% CI 3.14–3.47) and 7,087 had a first stroke (RR = 2.47, 95% CI 2.24–2.74). Adjusted incidence rates of these conditions in women with diabetes increased with duration of diabetes, obesity, inactivity and smoking. The 5-year adjusted incidence rates for cardiovascular disease were 4.6 (95% CI 4.4–4.9) per 100 women aged 50–69 in non-smokers with diabetes, 5.9 (95% CI 4.6–7.6) in smokers with diabetes not using insulin and 11.0 (95% CI 8.3–14.7) in smokers with diabetes using insulin. Non-smoking women with diabetes who were not overweight or inactive still had threefold increased rate for coronary disease or stroke compared with women without diabetes. Of the modifiable factors examined in middle aged women with diabetes, smoking causes the greatest increase in cardiovascular disease, especially in those with insulin treated diabetes.
Literatur
2.
5.
Zurück zum Zitat Barrett-Connor EL, Cohn BA, Wingard DL, Edelstein SL. Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study. JAMA. 1991;265:627–31. doi:10.1001/jama.265.5.627.PubMedCrossRef Barrett-Connor EL, Cohn BA, Wingard DL, Edelstein SL. Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study. JAMA. 1991;265:627–31. doi:10.​1001/​jama.​265.​5.​627.PubMedCrossRef
6.
Zurück zum Zitat Folsom AR, Rasmussen ML, Chambless LE, Howard G, Cooper LS, Shmidt MI, et al. Prospective associations of fasting insulin, body fat distribution, and diabetes with risk of ischemic stroke. Diabetes Care. 1999;22:1077–83. doi:10.2337/diacare.22.7.1077.PubMedCrossRef Folsom AR, Rasmussen ML, Chambless LE, Howard G, Cooper LS, Shmidt MI, et al. Prospective associations of fasting insulin, body fat distribution, and diabetes with risk of ischemic stroke. Diabetes Care. 1999;22:1077–83. doi:10.​2337/​diacare.​22.​7.​1077.PubMedCrossRef
9.
Zurück zum Zitat Janghorbani M, Hu FB, Willett WC, Li TY, Manson JE, Logroscino G, et al. Prospective study of Type 1 and Type 2 diabetes and risk of stroke subtypes. Diabetes Care. 2007;30:1730–5. doi:10.2337/dc06-2363.PubMedCrossRef Janghorbani M, Hu FB, Willett WC, Li TY, Manson JE, Logroscino G, et al. Prospective study of Type 1 and Type 2 diabetes and risk of stroke subtypes. Diabetes Care. 2007;30:1730–5. doi:10.​2337/​dc06-2363.PubMedCrossRef
12.
Zurück zum Zitat Stamler J, Vaccaro O, Neaton JD, Wentworth D, Multiple Risk Factor Intervention Trial Research Group. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care. 1993;16:434–43. doi:10.2337/diacare.16.2.434.PubMedCrossRef Stamler J, Vaccaro O, Neaton JD, Wentworth D, Multiple Risk Factor Intervention Trial Research Group. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care. 1993;16:434–43. doi:10.​2337/​diacare.​16.​2.​434.PubMedCrossRef
13.
Zurück zum Zitat Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:937–52. doi:10.1016/S0140-6736(04)17018-9.PubMedCrossRef Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:937–52. doi:10.​1016/​S0140-6736(04)17018-9.PubMedCrossRef
14.
Zurück zum Zitat The Million Women Study Collaborative Group. The Million Women Study: design and characteristics of the study population. Breast Cancer Res. 1999;1:73–80. doi:10.1186/bcr16.CrossRef The Million Women Study Collaborative Group. The Million Women Study: design and characteristics of the study population. Breast Cancer Res. 1999;1:73–80. doi:10.​1186/​bcr16.CrossRef
17.
Zurück zum Zitat World Health Organization. International Statistical Classification of Diseases and Related Health Problems, vol. 1. Geneva: World Health Organization; 1992. World Health Organization. International Statistical Classification of Diseases and Related Health Problems, vol. 1. Geneva: World Health Organization; 1992.
19.
20.
Zurück zum Zitat McIntosh A, Hutchinson A, Home PD, Brown F, Bruce A, Damerell A, et al. Clinical guidelines and evidence review for Type 2 diabetes: management of blood glucose. Sheffield: ScHARR, University of Sheffield; 2001. McIntosh A, Hutchinson A, Home PD, Brown F, Bruce A, Damerell A, et al. Clinical guidelines and evidence review for Type 2 diabetes: management of blood glucose. Sheffield: ScHARR, University of Sheffield; 2001.
21.
Zurück zum Zitat Banks E, Beral V, Cameron R, Hogg A, Langley N, Barnes I, et al. Agreement between general practice prescription data and self-reported use of hormone replacement therapy and treatment for various illnesses. J Epidemiol Biostat. 2001;6:357–63. doi:10.1080/13595220152601837.PubMedCrossRef Banks E, Beral V, Cameron R, Hogg A, Langley N, Barnes I, et al. Agreement between general practice prescription data and self-reported use of hormone replacement therapy and treatment for various illnesses. J Epidemiol Biostat. 2001;6:357–63. doi:10.​1080/​1359522015260183​7.PubMedCrossRef
22.
Zurück zum Zitat Bush TL, Miller SR, Golden AL, Hale WE. Self-report and medical record agreement of selected medical conditions in the elderly. Am J Public Health. 1989;79:1554–6.PubMedCrossRef Bush TL, Miller SR, Golden AL, Hale WE. Self-report and medical record agreement of selected medical conditions in the elderly. Am J Public Health. 1989;79:1554–6.PubMedCrossRef
23.
Zurück zum Zitat UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–53. doi:10.1016/S0140-6736(98)07019-6.CrossRef UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–53. doi:10.​1016/​S0140-6736(98)07019-6.CrossRef
24.
Zurück zum Zitat Nathan DM, Cleary PA, Backlund JYC, Genuth SM, Lachin JM, Orchard TJ, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005;353:2643–53. doi:10.1056/NEJMoa052187.PubMedCrossRef Nathan DM, Cleary PA, Backlund JYC, Genuth SM, Lachin JM, Orchard TJ, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005;353:2643–53. doi:10.​1056/​NEJMoa052187.PubMedCrossRef
25.
Zurück zum Zitat Banks E, Beral V, Cameron R, Hogg A, Langley N, Barnes I, et al. Comparison of various characteristics of women who do and do not attend for breast cancer screening. Breast Cancer Res. 2002;4(1):R1. doi:10.1186/bcr418.PubMedCrossRef Banks E, Beral V, Cameron R, Hogg A, Langley N, Barnes I, et al. Comparison of various characteristics of women who do and do not attend for breast cancer screening. Breast Cancer Res. 2002;4(1):R1. doi:10.​1186/​bcr418.PubMedCrossRef
26.
Zurück zum Zitat The West of Scotland Coronary Prevention Study Group. Computerised record linkage: compared with traditional patient follow-up methods in clinical trials and illustrated in a prospective epidemiological study. J Clin Epidemiol. 1995;48:1441–52. doi:10.1016/0895-4356(95)00530-7.CrossRef The West of Scotland Coronary Prevention Study Group. Computerised record linkage: compared with traditional patient follow-up methods in clinical trials and illustrated in a prospective epidemiological study. J Clin Epidemiol. 1995;48:1441–52. doi:10.​1016/​0895-4356(95)00530-7.CrossRef
27.
Zurück zum Zitat Kendrick S, Clarke J. The Scottish Record Linkage System. Health Bull (Edinb). 1993;51:72–9. Kendrick S, Clarke J. The Scottish Record Linkage System. Health Bull (Edinb). 1993;51:72–9.
28.
Zurück zum Zitat Information and Statistics Division NHS Scotland. NHS Scotland Quality Assurance Report on Acute Inpatient/Day case Data 2001–2002, Vol. 2005. Scotland: ISD; 2004. Information and Statistics Division NHS Scotland. NHS Scotland Quality Assurance Report on Acute Inpatient/Day case Data 2001–2002, Vol. 2005. Scotland: ISD; 2004.
Metadaten
Titel
Diabetes and modifiable risk factors for cardiovascular disease: the prospective Million Women Study
verfasst von
Elizabeth A. Spencer
Kirstin L. Pirie
Richard J. Stevens
Valerie Beral
Anna Brown
Bette Liu
Jane Green
Gillian K. Reeves
Million Women Study Collaborators
Publikationsdatum
01.12.2008
Verlag
Springer Netherlands
Erschienen in
European Journal of Epidemiology / Ausgabe 12/2008
Print ISSN: 0393-2990
Elektronische ISSN: 1573-7284
DOI
https://doi.org/10.1007/s10654-008-9298-3

Weitere Artikel der Ausgabe 12/2008

European Journal of Epidemiology 12/2008 Zur Ausgabe